Purchase Order HT001425PE079
Award Date 9/30/25
Potential Completion Date 9/29/26
Potential Value $84K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Italy
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Health Agency awarded a firm fixed-price delivery order to Ortho-Clinical Diagnostics, Inc. valued at $303,629.39 for cost-per-test laboratory chemistry analysis services utilizing the ORTHO VITROS Analyzer. This delivery order, effective through September 30, 2025, was issued without a set-aside designation under the Critical Analyzers, Laboratory (FSS-66-III) General Services Administration Schedule. Performance will be conducted at the contractor's facility in Raritan, New Jersey....
- Ortho-Clinical Diagnostics, Inc. has been awarded a delivery order valued at $456,420 by the Defense Health Agency for an analyzer and associated reagents, with performance to be completed by September 30, 2026. The contract, which became effective October 1, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating competition among qualified vendors. Work will be performed at the company's facility in Raritan, New Jersey. As a leading medical...
- Ortho-Clinical Diagnostics, Inc. has been awarded a delivery order valued at $794,067.40 by the Defense Health Agency for orthovision supplies, reagents, and maintenance services in support of orthopedics clinical diagnostics. Issued on September 30, 2024, with an ultimate completion date of September 30, 2028, this firm fixed-price contract represents an unrestricted competitive award with no set-aside designation. The work will be performed at the company's headquarters in Raritan, New Jersey....
- Ortho-Clinical Diagnostics, Inc. was awarded a firm fixed-price delivery order valued at $193.4K by the Defense Health Agency on March 26, 2024, for cost-per-test reagents, equipment, and service related to Ortho Vision Analyzers. The contract, which extends through September 30, 2026, will be performed at the contractor's facility in Raritan, New Jersey. This delivery order was issued without a set-aside designation, indicating open competition, and is structured under the Critical Analyzers,...
- The Defense Health Agency awarded Ortho-Clinical Diagnostics, Inc. a firm fixed-price purchase order valued at $107,550.60 for ortho blood bank reagents on April 17, 2023. The contract, which has no set-aside designation and reflects open competition, will be performed at Fort Irwin, California, with an ultimate completion date of April 16, 2028. Ortho-Clinical Diagnostics is a medical equipment manufacturer headquartered in Raritan, New Jersey, specializing in advanced diagnostic solutions...
- The Defense Health Agency awarded a delivery order valued at $306,440.38 to Ortho-Clinical Diagnostics, Inc. on September 24, 2022, for chemistry analyzer equipment and laboratory reagents, with an ultimate completion date of June 30, 2026. This firm fixed-price contract was awarded without a set-aside designation under the Critical Analyzers, Laboratory (FSS-66-III) General Services Administration Schedule. The work will be performed in Raritan, New Jersey, where Ortho-Clinical Diagnostics...
- The Defense Health Agency awarded a $172,221.60 firm fixed-price delivery order to Ortho-Clinical Diagnostics, Inc. for blood bank microtyping system reagents, with an ultimate completion date of September 30, 2030. This delivery order, issued without a set-aside designation, represents an open competition award under the Critical Analyzers, Laboratory (FSS-66-III) GSA Schedule. Performance will occur at Ortho-Clinical Diagnostics' facility in Raritan, New Jersey, where the company...
- Ortho-Clinical Diagnostics, Inc. was awarded a firm fixed-price purchase order valued at $697,872.95 by the Defense Health Agency on May 18, 2022, for the supply of chemistry analyzers and reagents to support clinical laboratory services. The contract, with an ultimate completion date of September 30, 2026, stems from a Department of the Army Medical Command solicitation seeking fully automated integrated chemistry/immunoassay analyzers, associated reagents, and data management systems for the...
- The Defense Health Agency awarded a delivery order valued at $641,516.80 to Ortho-Clinical Diagnostics, Inc. for reagents and consumables to support laboratory operations at Fort Belvoir, Virginia. This firm fixed-price delivery order, issued under the Critical Analyzers, Laboratory (FSS-66-III) GSA Schedule, carries an ultimate completion date of April 30, 2030, and represents an open competition contract with no set-aside designation. Ortho-Clinical Diagnostics, a medical equipment...
- Ortho-Clinical Diagnostics, Inc. was awarded a delivery order contract by the Defense Health Agency valued at $585,539.13 for the provision of cost-per-test chemistry analyzer services and chemical reagents. The contract, which carries a firm fixed-price structure with no set-aside designation, operates under the Critical Analyzers, Laboratory (FSS-66-III) General Services Administration Schedule and is scheduled for completion by March 31, 2026. Performance will be executed at the company's...